The ROE as of November 2024 (TTM) for China Pharma Holdings, Inc. (CPHI) is -60.19%

According to China Pharma Holdings, Inc.’s latest financial reports and current stock price. The company's current ROE is -60.19%. This represents a change of 299.97% compared to the average of -15.05% of the last 4 quarters.

China Pharma Holdings, Inc. (CPHI) Historical ROE (quarterly & annually)

How has CPHI ROE performed in the past?

The mean historical ROE of China Pharma Holdings, Inc. over the last ten years is -75.38%. The current -60.19% ROE has changed -20.15% with respect to the historical average. Over the past ten years (40 quarters), CPHI's ROE was at its highest in in the September 2015 quarter at 3.38%. The ROE was at its lowest in in the December 2019 quarter at -202.92%.

China Pharma Holdings, Inc. (CPHI) ROE by Quarter and Year

Discovering the peaks and valleys of China Pharma Holdings, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

China Pharma Holdings, Inc. (CPHI) Average ROE

How has CPHI ROE performed in the past?

The current ROE of China Pharma Holdings, Inc. (CPHI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

China Pharma Holdings, Inc. (CPHI) ROE vs. Peers

How is CPHI’s ROE compared to its peers?

China Pharma Holdings, Inc.’s ROE is greater than Universe Pharmaceuticals INC (-55.97%), greater than Sonoma Pharmaceuticals, Inc. (-77.69%), less than Acorda Therapeutics, Inc. (485.80%), greater than Akanda Corp. (-753.35%), greater than Halo Collective Inc. (-234.02%), greater than Alimera Sciences, Inc. (-33.70%), greater than China SXT Pharmaceuticals, Inc. (-83.62%), greater than Petros Pharmaceuticals, Inc. (-134.64%), greater than Biofrontera Inc. (-477.13%), greater than Guardion Health Sciences, Inc. (-71.26%), greater than Shuttle Pharmaceuticals Holdings, Inc. (-217.58%), less than Green Cures & Botanical Distribution Inc. (89.83%), greater than Cann American Corp. (-80.83%), less than Rimrock Gold Corp. (8.44%), greater than Galexxy Holdings, Inc. (-150.41%), less than Indoor Harvest Corp (763.57%), greater than Mallinckrodt plc (-117.04%), less than Lifecore Biomedical, Inc. (17.23%), greater than Lucy Scientific Discovery Inc. (-377.80%), less than Adamis Pharmaceuticals Corporation (0.93%),

Build a custom stock screener for China Pharma Holdings, Inc. (CPHI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like China Pharma Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

China Pharma Holdings, Inc. (CPHI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like China Pharma Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.